A Randomized Phase III, Factorial Design, of Cabazitaxel and Pelvic Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse
Phase of Trial: Phase III
Latest Information Update: 21 Feb 2018
At a glance
- Drugs Cabazitaxel (Primary) ; Antiandrogens; LHRH receptor agonists; LHRH receptor antagonists
- Indications Prostate cancer
- Focus Registrational; Therapeutic Use
- Acronyms PEACE2
- Sponsors UNICANCER
- 10 Jun 2017 Biomarkers information updated
- 02 Jun 2014 The study protocol presented at 50th Annual Meeting of the American Society of Clinical Oncology.
- 24 Jan 2014 Status changed from active, no longer recruiting to recruiting as per ClinicalTrials.gov record.